Needham analyst Mike Matson upgraded Surmodics to Buy from Hold with a $36 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SRDX:
Needham analyst Mike Matson upgraded Surmodics to Buy from Hold with a $36 price target.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SRDX: